ruxolitinibum 5 mg ut ruxolitinibi hydrochloridum, lactosum monohydricum 75.005 mg, cellulosum microcristallinum, povidonum K 29-32, hydroxypropylcellulosum, carboxymethylamylum natricum A, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium max. 0.43 mg.
Packungsbestandteile
Tablets
Active Agent
Dose
Ruxolitinibum
5 mg
Inactive agents
Dose
Carboxymethylamylum Natricum A
Cellulosum Microcristallinum
Hydroxypropylcellulosum
Lactose Monohydrate
75.005 mg
Magnesii Stearas
Povidonum K
29-32
Pro Compresso
Silica Colloidalis Anhydrica
Source
Data was imported : 05.06.2026
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
